Sex determinants of experimental panic attacks

被引:14
作者
Lovick, Thelma A. [1 ]
机构
[1] Univ Bristol, Bristol BS8 1TD, Avon, England
关键词
Panic; Animal models; Females; Periaqueductal gray; Progesterone withdrawal; Allopregnanolone; Menstrual cycle; Mouse; Rat; PREMENSTRUAL DYSPHORIC DISORDER; PERIAQUEDUCTAL GREY-MATTER; RECEPTOR SUBUNIT EXPRESSION; CARBON-DIOXIDE INHALATION; CYCLE-DEPENDENT CHANGES; ELEVATED T-MAZE; ESTROUS-CYCLE; GABA(A) RECEPTOR; MENSTRUAL-CYCLE; FEMALE RATS;
D O I
10.1016/j.neubiorev.2014.03.006
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Panic disorder is twice a common in women than in men. In women, susceptibility to panic increases during the late luteal (premenstrual) phase of the menstrual cycle, when progesterone secretion is in rapid decline. This article considers the evidence for the midbrain periaqueductal grey (PAG) as a locus for panic and for the use of PAG stimulation as an animal model of panic in both sexes. We show in females how a rapid fall in progesterone secretion, such as occurs during the late dioestrus phase of the ovarian cycle in rats (similar to the late luteal phase in women), triggers a neuronal withdrawal response during which the excitability of the midbrain panic circuitry increases as a result of upregulation of extrasynaptic GABA(A) receptors on inhibitory interneurones in the PAG. The withdrawal effect is due not to the native hormone but to its neuroactive metabolite allopregnanolone. Differences in the kinetics of allopregnanolone metabolism may contribute to individual differences in susceptibility to panic in women. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:465 / 471
页数:7
相关论文
共 99 条
[31]   NEUROSTEROID WITHDRAWAL REGULATES GABA-A RECEPTOR α4-SUBUNIT EXPRESSION AND SEIZURE SUSCEPTIBILITY BY ACTIVATION OF PROGESTERONE RECEPTOR-INDEPENDENT EARLY GROWTH RESPONSE FACTOR-3 PATHWAY [J].
Gangisetty, O. ;
Reddy, D. S. .
NEUROSCIENCE, 2010, 170 (03) :865-880
[32]   The epidemiology of panic disorder and agoraphobia in Europe [J].
Goodwin, RD ;
Faravelli, C ;
Rosi, S ;
Cosci, F ;
Truglia, E ;
de Graaf, R ;
Wittchen, HU .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (04) :435-443
[33]   Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder - Evidence for a central fear mechanism [J].
Gorman, JM ;
Kent, J ;
Martinez, J ;
Browne, S ;
Coplan, J ;
Papp, LA .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (02) :125-131
[34]   Influence of the estrous cycle on the behavior of rats in the elevated T-maze [J].
Gouveia, A ;
dos Santos, UD ;
Felisbino, FE ;
de Afonseca, TL ;
Antunes, G ;
Morato, S .
BEHAVIOURAL PROCESSES, 2004, 67 (02) :167-171
[35]   The elevated T-maze as an experimental model of anxiety [J].
Graeff, FG ;
Netto, CF ;
Zangrossi, H .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1998, 23 (02) :237-246
[36]   Predator-elicited flight responses in Swiss-Webster an experimental model of panic attacks [J].
Griebel, G ;
Blanchard, DC ;
Blanchard, RJ .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1996, 20 (02) :185-205
[37]   Withdrawal from progesterone increases expression of α4, β1, and δ GABAA receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats [J].
Griffiths, J ;
Lovick, T .
JOURNAL OF COMPARATIVE NEUROLOGY, 2005, 486 (01) :89-97
[38]   Gabaergic neurones in the rat periaqueductal grey matter express α4, β1 and δ GABAA receptor subunits:: Plasticity of expression during the estrous cycle [J].
Griffiths, JL ;
Lovick, TA .
NEUROSCIENCE, 2005, 136 (02) :457-466
[39]   Sex differences in anxiety, sensorimotor gating and expression of the α4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal [J].
Gulinello, M ;
Orman, R ;
Smith, SS .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (03) :641-648
[40]   Progesterone withdrawal increases the α4 subunit of the GABAA receptor in male rats in association with anxiety and altered pharmacology -: a comparison with female rats [J].
Gulinello, M ;
Gong, QH ;
Smith, SS .
NEUROPHARMACOLOGY, 2002, 43 (04) :701-714